Literature DB >> 62844

Deficits in reticuloendothelial humoral control mechanisms in patients after trauma.

W A Scovill, T M Saba, J E Kaplan, H Bernard, S Powers.   

Abstract

Plasma opsonic activity as expressed by an alpha-2-globulin which stimulates hepatic Kupffer cell phagocytosis, and thus modulates RES clearance, was determined in patients at varying intervals following whole-body trauma. Plasma opsonic activity decreased markedly following trauma in both nonsurviving (NS) and surviving (S) trauma patients as compared to an age- and sex-matched group of healthy volunteers. The initial post-traumatic hypoopsonemia (0-72 hr) was more severe (p less than 0.01) in nonsurviving patients than surviving patients. Survivors following trauma manifested restoration of opsonin levels with a definite transient rebound hyperopsonemia during the recovery phase (11-30 days); nonsurviving patients exhibited persistent systemic alpha-2-globulin opsonic deficiency. On the basis of previous animal and human studies, the presently observed humoral deficits following trauma in patients could contribute to impairment of reticuloendothelial Kupffer cell clearance of blood-borne particulate matter such as fibrin, damaged platelets, and other altered autologous tissue. The importance of post-trauma RES dysfunction to survival following severe injury warrants further investigation and clinical consideration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62844     DOI: 10.1097/00005373-197611000-00008

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  16 in total

1.  Beneficial effect of enhanced macrophage function in the trauma patient.

Authors:  W Browder; D Williams; H Pretus; G Olivero; F Enrichens; P Mao; A Franchello
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

Review 2.  Fibronectin and phagocytosis.

Authors:  H Hörmann
Journal:  Blut       Date:  1985-11

Review 3.  The adult respiratory distress syndrome--20 years on.

Authors:  D J Shale
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

Review 4.  Immunologic aspects of fibronectin.

Authors:  J K Czop
Journal:  Surv Immunol Res       Date:  1982

Review 5.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

Review 6.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

7.  Fibronectin--mediator between cells and connective tissue.

Authors:  H Hörmann
Journal:  Klin Wochenschr       Date:  1982-10-15

8.  Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

Authors:  W A Scovill; T M Saba; F A Blumenstock; H Bernard; S R Powers
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

9.  Fibronectin in blood products--an in vitro and in vivo study.

Authors:  J T Reilly; B A McVerry; M J Mackie
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

10.  Reversal of fibronectin and opsonic deficiency in patients. A controlled study.

Authors:  T M Saba; F A Blumenstock; D M Shah; J E Kaplan; E Cho; W Scovill; H Stratton; J Newell; M Gottlieb; N Sedransk
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.